The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, and the gravity of unmet needs, as well as the growing importance of technologies such as pharmacogenomics, digital therapeutics, and artificial intelligence. In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Immuno-oncology in Pharmaceuticals: In-vitro T-cell activation. Buy the report here.

Smarter leaders trust GlobalData

According to GlobalData’s Technology Foresights, which uses over 756,000 patents to analyse innovation intensity for the pharmaceutical industry, there are 110 innovation areas that will shape the future of the industry.

In-vitro T-cell activation is a key innovation area in immuno-oncology

T cells can be activated and differentiated in vitro by crosslinking the TCR with CD3 antibodies and PMA treatment. Activation of T-cell proliferation specifically in a tumour is crucial for reducing the autoimmune side effects of antitumour immunotherapy. T-cell activation can be measured by assessing proliferation, up-regulation of activation markers and production of effector cytokines (IFN-gamma and TNF-alpha).

GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies.  According to GlobalData, there are 210+ companies, spanning technology vendors, established pharmaceutical companies, and up-and-coming start-ups engaged in the development and application of in-vitro T-cell activation.

Key players in in-vitro T-cell activation – a disruptive innovation in the pharmaceutical industry

‘Application diversity’ measures the number of different applications identified for each relevant patent and broadly splits companies into either ‘niche’ or ‘diversified’ innovators.

‘Geographic reach’ refers to the number of different countries each relevant patent is registered in and reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’.

Patent volumes related to in-vitro T-cell activation

Company Total patents (2010 - 2022) Premium intelligence on the world's largest companies
Immatics 2002 Unlock Company Profile
Bristol-Myers Squibb 632 Unlock Company Profile
Cellectis 486 Unlock Company Profile
bluebird bio 271 Unlock Company Profile
City of Hope 267 Unlock Company Profile
Autolus 260 Unlock Company Profile
Fred Hutchinson Cancer Research Center 246 Unlock Company Profile
Memorial Sloan Kettering Cancer Center 216 Unlock Company Profile
Gilead Sciences 202 Unlock Company Profile
CARsgen Therapeutics 137 Unlock Company Profile
Seattle Children's Hospital 116 Unlock Company Profile
Nanjing Legend Biotech 112 Unlock Company Profile
Miltenyi Biotec 111 Unlock Company Profile
Regeneron Pharmaceuticals 104 Unlock Company Profile
CRISPR Therapeutics 96 Unlock Company Profile
Allogene Therapeutics 94 Unlock Company Profile
Adaptimmune Therapeutics 92 Unlock Company Profile
Precision Biosciences 89 Unlock Company Profile
Pfizer 84 Unlock Company Profile
BioNTech 80 Unlock Company Profile
Eureka Therapeutics 79 Unlock Company Profile
PT Soho Global Health Tbk 78 Unlock Company Profile
Innovative Cellular Therapeutics 75 Unlock Company Profile
TCR2 Therapeutics 70 Unlock Company Profile
United States Of America 68 Unlock Company Profile
Sangamo Therapeutics 66 Unlock Company Profile
Poseida Therapeutics 65 Unlock Company Profile
iCell Gene Therapeutics 63 Unlock Company Profile
EXUMA Biotech 57 Unlock Company Profile
Takeda Pharmaceutical 54 Unlock Company Profile
Intima Bioscience 53 Unlock Company Profile
Editas Medicine 51 Unlock Company Profile
Genscript Biotech 50 Unlock Company Profile
Amgen 47 Unlock Company Profile
Pact Pharma 45 Unlock Company Profile
Adicet Bio 44 Unlock Company Profile
Fate Therapeutics 44 Unlock Company Profile
Noile-Immune Biotech 43 Unlock Company Profile
Gracell Biotechnologies 38 Unlock Company Profile
Instil Bio 37 Unlock Company Profile
Johnson & Johnson 37 Unlock Company Profile
2Seventy Bio 34 Unlock Company Profile
UAB Research Foundation 33 Unlock Company Profile
TRON gGmbH 33 Unlock Company Profile
CBMG Holdings 32 Unlock Company Profile
Alpine Immune Sciences 32 Unlock Company Profile
Precigen 31 Unlock Company Profile
KSQ Therapeutics 30 Unlock Company Profile
Shanghai Unicar-Therapy Bio-Medicine Technology 29 Unlock Company Profile
HRAIN Biotechnology 28 Unlock Company Profile

Source: GlobalData Patent Analytics

Immatics is the leading patent filer in in-vitro T-cell activation. Immatics is a biopharmaceutical company focused on the development of T-cell immunotherapies to fight against cancer. Immatics has established two proprietary cancer cell target and TCR discovery platforms, namely XPRESIDENT and XCEPTOR. In 2022, Immatics and Editas Medicine entered a research collaboration and licensing agreement to combine gamma-delta T-cell adoptive cell therapies and gene editing to develop medicines for the treatment of cancer. Bristol-Myers Squibb and Cellectis are the other key patent filers in in-vitro T-cell activation.

In terms of application diversity, Gritstone Bio is the top company, followed by Merck and Targovax. By means of geographic reach, Systimmune holds the top position. Sichuan Baili Pharmaceutical and AbbVie stand in second and third positions, respectively. To further understand the key themes and technologies disrupting the pharmaceutical industry, access GlobalData’s latest thematic research report on Immuno-Oncology – Thematic Research.

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Patent Analytics tracks patent filings and grants from official offices around the world. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.